Search Results - Sanmamed, M.F.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    OA09.04 Spatial Mapping and Clinical Significance of the LAG-3/FGL1 Pathway in Non-small Cell Lung Cancer Using High-Dimensional Tissue Imaging

    OA09.04 Spatial Mapping and Clinical Significance of the LAG-3/FGL1 Pathway in Non-small Cell Lung Cancer Using High-Dimensional Tissue Imaging by Desai, S.S., Sanmamed, M.F., Wang, J., Schalper, K.A.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    OA01.05 Phase I Dose Escalation Trial Of The DLL3/CD3 Igg-Like T Cell Engager BI 764532 In Patients with DLL3+ Tumors: Focus on SCLC

    OA01.05 Phase I Dose Escalation Trial Of The DLL3/CD3 Igg-Like T Cell Engager BI 764532 In Patients with DLL3+ Tumors: Focus on SCLC by Wermke, M., Kuboki, Y., Felip, E., Alese, O.B., Morgensztern, D., Sayehli, C., Arriola, E., Sanmamed, M.F., Oum’ Hamed, Z., Song, E., Studeny, M., Gambardella, V.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    143P CISPLATINUM PLUS DOCETAXEL (CD) AS INDUCTION CHEMOTHERAPY PRIOR TO RADICAL LOCOREGIONAL (LR) TREATMENT FOR PATIENTS (PTS) WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PROSPECTIVE PHASE II STUDY

    143P CISPLATINUM PLUS DOCETAXEL (CD) AS INDUCTION CHEMOTHERAPY PRIOR TO RADICAL LOCOREGIONAL (LR) TREATMENT FOR PATIENTS (PTS) WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RE... by Berros, J.P, Esteban, E, Crespo, G, Muriel, C, Sanmamed, M.F, Pardo, P, Izquierdo, M, Fonseca, P.J, Luque, M, Olay, L

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: